Phase I/II Study: Combination Rigosertib and Azacitidine in Patients with MDS or AML - Смотреть видео или скачать видео в MP4, музыку MP3 на телефон или компьютер
At ASH 2014, Dr. Shyamala Navada discussed her abstract 3252 on a phase I/II study of the combination of oral rigosertib and azacitidine in patients with MDS or AML For more oncology news, education, and information, please visit [ Ссылка ]
